In vivo regulation of plasminogen function by plasma carboxypeptidase B

被引:92
作者
Swaisgood, CM
Schmitt, D
Eaton, D
Plow, EF
机构
[1] Cleveland Clin Fdn, Dept Mol Cardiol, Cleveland, OH 44195 USA
[2] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA
关键词
D O I
10.1172/JCI200215082
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The major functions of plasminogen (Plg) in fibrinolysis and cell migration depend on its binding to carboxy-terminal lysyl residues. The ability of plasma carboxypeptidase B (pCPB) to remove these residues suggests that it may act as a suppressor of these Plg functions. To evaluate this role of pCPB in vivo, homozygote pCPB-deficient mice were generated by homologous recombination, and the resulting pCPB(-/-) mice, which were viable and healthy, were mated to Plg(-/-) mice. Plg(+/-) mice show intermediate levels of fibrinolysis and cell migration compared with Plg wild-type and deficient mice, reflecting the intermediate levels of the Plg antigen in their plasma. Differences in Plg-dependent functions between pCPB(+/+), pCPB(+/-) and pCPB(-/-) mice were then analyzed in a Plg(+/-) background. in a pulmonary clot lysis model, fibrinolysis was significantly increased in mice with partial (pCPB(+/-)) or total absence (pCPB(-/-)) of pCPB compared with their wild-type counterparts (pCPB(+/+)). In a thioglycollate model of peritoneal inflammation, leukocyte migration at 72 hours increased significantly in Plg(+/-)/pCPB(+/-) and Plg(+/-)/pCPB(-/-) compared with their wild-type counterparts. These studies demonstrate a definitive role of pCPB as a modulator of the pivotal functions of Plg in fibrinolysis and cell migration in vivo.
引用
收藏
页码:1275 / 1282
页数:8
相关论文
共 57 条
[1]   TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex [J].
Bajzar, L ;
Morser, J ;
Nesheim, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16603-16608
[2]   PURIFICATION AND CHARACTERIZATION OF TAFI, A THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR [J].
BAJZAR, L ;
MANUEL, R ;
NESHEIM, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14477-14484
[3]  
BIERMOND BJ, 2001, BLOOD, V98, pA255
[4]  
BRADLEY A, 1987, PRODUCTION ANAL CHIM, P113
[5]   PLASMINOGEN DEFICIENCY CAUSES SEVERE THROMBOSIS BUT IS COMPATIBLE WITH DEVELOPMENT AND REPRODUCTION [J].
BUGGE, TH ;
FLICK, MJ ;
DAUGHERTY, CC ;
DEGEN, JL .
GENES & DEVELOPMENT, 1995, 9 (07) :794-807
[7]   Impaired arterial neointima formation in mice with disruption of the plasminogen gene [J].
Carmeliet, P ;
Moons, L ;
Ploplis, V ;
Plow, E ;
Collen, D .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (02) :200-208
[8]   PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .2. EFFECTS ON HEMOSTASIS, THROMBOSIS, AND THROMBOLYSIS [J].
CARMELIET, P ;
STASSEN, JM ;
SCHOONJANS, L ;
REAM, B ;
VANDENOORD, JJ ;
DEMOL, M ;
MULLIGAN, RC ;
COLLEN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2756-2760
[9]   Plasma TAFI antigen variations in healthy subjects [J].
Chetaille, P ;
Alessi, MC ;
Kouassi, D ;
Morange, PE ;
Juhan-Vague, I .
THROMBOSIS AND HAEMOSTASIS, 2000, 83 (06) :902-905
[10]   Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction [J].
Creemers, E ;
Cleutjens, J ;
Smits, J ;
Heymans, S ;
Moons, L ;
Collen, D ;
Daemen, M ;
Carmeliet, P .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (06) :1865-1873